That grapevine is wrong. I don't doubt IMDS is in talks with lenders, but I can guarantee they aren't competing in a good way. It more of the lessor of the evils, on who's offering the best deal on horrid toxic conversion terms.
IMDS will not get non-toxic financing. I imagine Southridge is close to cutting off funding, if the havent already.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.